Welcome to 247healthcare

Probiotics with Antibiotics: A Doctor-Reviewed Evidence Guide

10 min read Updated 31 May 2026 Medically reviewed

Disclosure: 247healthcare.blog publishes general health education reviewed by qualified doctors. Some articles contain affiliate links. This post does not. Our editorial process and medical review are independent of any commercial relationship. Full disclosure policy.

Key takeaways

  • Antibiotic-associated diarrhoea (AAD) affects 5 to 25 percent of adults on antibiotics. The most serious form is Clostridioides difficile colitis, which can be life-threatening.
  • The American Gastroenterological Association 2020 guideline recommends specific probiotic formulations for C. difficile prevention in adults and children taking antibiotics. Cochrane reviews of AAD and C. difficile prevention show benefit with appropriate strains.
  • Strain selection matters more than brand or CFU count. The strongest evidence is for Saccharomyces boulardii CNCM I-745, Lactobacillus rhamnosus GG, and AGA-listed multi-strain formulations.
  • Take the probiotic at least 2 hours after the antibiotic, throughout the course and for at least 1 week after. Start within 48 hours of the first antibiotic dose.
  • Five groups should avoid routine probiotics: critically ill ICU patients, severely immunocompromised patients, those with central venous catheters, premature infants outside specialised neonatal protocols, and anyone with previous probiotic-associated bloodstream infection.

Medically reviewed by Dr. Ravi Sishir Reddy (MBBS, MD General Medicine), Internal Medicine and Critical Care, with 15 years of clinical experience including ICU and infectious disease management. NMC-registered, verifiable on the Indian Medical Register.

Whether to take probiotics during a course of antibiotics is one of the most common questions a patient asks at the pharmacy. The short answer is yes for most healthy adults, with specific strains, at the right time, for the full duration. The longer answer is that not all probiotics are equal, the evidence is strain-specific not brand-specific, and a small group of patients should not take them at all. This guide walks through what the actual guidelines say, which strains have data, how to take them correctly, and the situations where the small but real risk outweighs the benefit.

What antibiotic-associated diarrhoea is

Antibiotic-associated diarrhoea (AAD) is loose, watery stools that develop during or up to 8 weeks after a course of antibiotics. It happens because antibiotics do not just kill the bacteria causing your infection, they also disrupt the trillions of helpful bacteria in your gut. The disruption changes how your gut absorbs water and ferments fibre, which can produce diarrhoea.

5 to 25%

Adults develop antibiotic-associated diarrhoea on a typical course, depending on the antibiotic, the duration, and individual factors. Broad-spectrum drugs like amoxicillin-clavulanate, clindamycin, and fluoroquinolones cause AAD more often than narrow-spectrum agents.

Most AAD is mild and self-limiting. The stools become loose within a few days of starting the antibiotic, sometimes after the course ends, and resolve when gut flora recovers over the following 2 to 4 weeks. Hydration and a bland diet usually carry you through.

The more serious form, which is what most of the probiotic evidence focuses on, is Clostridioides difficile colitis. This is a separate clinical problem that needs its own section.

Clostridioides difficile, the serious form

Clostridioides difficile (also called C. diff) is a bacterium that lives in small numbers in the gut of around 5 percent of healthy adults. When antibiotics wipe out the competing flora, C. difficile can multiply unchecked and release toxins that inflame the colon. The result is C. difficile colitis: profuse watery diarrhoea (often 10 or more times a day), fever, abdominal cramps, and sometimes blood in the stool.

It is more common in older adults, in hospital settings, after prolonged or broad-spectrum antibiotic courses, and in patients with reduced stomach acid (proton pump inhibitor users). Severe cases need hospitalisation and treatment with specific antibiotics like vancomycin or fidaxomicin. Some cases lead to toxic megacolon, sepsis, or death.

The 2021 IDSA and SHEA focused update on C. difficile management is the standing professional guideline for treatment. Prevention is the focus of the probiotic discussion below.

Do probiotics actually help

The evidence has moved decisively toward yes, for specific strains at specific doses, in most adult and paediatric patients on antibiotics. Three independent evidence streams point in the same direction.

The Cochrane 2017 review of probiotics for the prevention of antibiotic-associated diarrhoea in children and adults found moderate-quality evidence of a protective effect, with a number-needed-to-treat around 25 to prevent one case of AAD.

The Cochrane 2019 review of probiotics for the prevention of C. difficile infection in adults and children found moderate-quality evidence that probiotics, taken concurrently with antibiotics, reduced the risk of C. difficile-associated diarrhoea by around 60 percent. The number-needed-to-treat was approximately 42 in moderate-to-high-risk groups.

The American Gastroenterological Association 2020 guideline recommends certain probiotic formulations for C. difficile prevention in adults and children taking antibiotics. This was a conditional recommendation based on moderate-certainty evidence.

Important nuance: the evidence is for specific strains and specific formulations, not for the category "probiotics" as a whole. A capsule labelled "multi-strain probiotic" without identification of the strains and doses used in clinical trials may or may not work. Strain identification is the essential check.

Which strains have evidence

Look at the label for the exact strain name, including the alphanumeric identifier. A strain like "Saccharomyces boulardii CNCM I-745" is not the same as a generic "Saccharomyces boulardii" entry without an identifier. Strains within the same species can have different clinical effects.

StrainStrongest evidence forTypical adult dose per day
Saccharomyces boulardii CNCM I-745AAD and C. difficile prevention in adults; AAD in children250 to 500 mg (5 to 10 billion CFU)
Lactobacillus rhamnosus GG (ATCC 53103)AAD in children; AAD in adults (less strong)5 to 10 billion CFU
Lactobacillus acidophilus CL1285 + Lactobacillus casei LBC80R (Bio-K+)C. difficile prevention in adults (AGA endorsed)50 to 100 billion CFU
3-strain combination: L. acidophilus + L. delbrueckii bulgaricus + B. bifidumC. difficile prevention (AGA endorsed)Per formulation labelling
4-strain combination: above 3 + Streptococcus thermophilusC. difficile prevention (AGA endorsed)Per formulation labelling
Lactobacillus reuteri DSM 17938Some evidence for paediatric AAD1 to 5 billion CFU
Bacillus clausii (O/C, SIN, N/R, T strains)Paediatric AAD per Asian expert consensus2 billion spores twice daily (paediatric)

Two practical filters when looking at a product. First, the label must name the strain with its identifier. Second, the daily CFU count should match what was used in the trials, typically in the billions, not millions. A capsule with 1 million CFU of an unspecified Lactobacillus is unlikely to do what you want.

How to take probiotics with antibiotics

Timing protocol

Start within 48 hours of the first antibiotic dose. Earlier is better. The goal is to maintain gut flora diversity from the start, not to rebuild after disruption.

Take the probiotic at least 2 to 3 hours after the antibiotic. The antibiotic concentration in your gut is highest in the first hour or two after a dose. Spacing prevents the live probiotic bacteria from being killed before they reach the colon. For example: antibiotic at 8 AM, probiotic at 11 AM or noon.

Continue throughout the antibiotic course and for at least 1 week after. Some specialists extend to 2 weeks post-antibiotic, especially after broad-spectrum agents like amoxicillin-clavulanate or fluoroquinolones, because gut flora recovery takes longer.

If you forget a probiotic dose: take it when you remember, but do not double up. Missing one dose is not harmful, missing a day is not harmful, but consistent daily intake gives the best benefit.

Storage: follow the label. Live-culture probiotics often need refrigeration after opening. Shelf-stable formulations like Saccharomyces boulardii capsules and Bacillus clausii spore suspensions tolerate room temperature.

Yogurt versus supplements

Most yogurt and curd contain useful live cultures, typically Lactobacillus bulgaricus and Streptococcus thermophilus, sometimes with added Lactobacillus acidophilus or Bifidobacterium. A typical serving contains 1 million to 100 million colony-forming units, depending on freshness, brand, and storage.

The doses used in clinical trials that showed AAD or C. difficile prevention were 1 to 50 billion CFU per day of specific identified strains. Yogurt typically provides 10 to 100 times less than this, of strains that may or may not be the ones with evidence for AAD prevention.

This does not mean yogurt is useless. Fermented dairy is a healthy food, has wider benefits, and provides modest gut support. But for the specific goal of preventing AAD or C. difficile during an antibiotic course, a clinically validated probiotic supplement with documented strains and CFU counts is the more reliable choice. Treat yogurt as a complementary food, not a replacement for the targeted intervention.

Other fermented foods (fresh kefir, fresh idli batter, well-fermented dosa batter, miso, kimchi, sauerkraut) are similarly good for gut health but face the same CFU limitation for prevention purposes.

Probiotic products available in India

India has a diverse probiotic market with both prescription and over-the-counter formulations. Common formulations a pharmacist may show you include:

  • Bacillus clausii, sold as Enterogermina by Sanofi, is widely prescribed and used. Asian expert consensus supports it for paediatric AAD. Adult evidence is more limited than for Saccharomyces boulardii, but the safety profile is good and availability is reliable.
  • Saccharomyces boulardii, sold under several brand names. Look for the CNCM I-745 strain identifier on the label to match the clinical trial evidence.
  • Lactobacillus and Bifidobacterium combinations, sold as various brand combinations. Useful, but check whether the label identifies specific strains and CFU counts. Generic "probiotic capsules" without strain identification may not work.
  • Curd, dahi, and traditional fermented foods are reasonable adjuncts but, as covered above, deliver too few CFU to substitute for a targeted probiotic during an antibiotic course.

Cost is usually modest, in the range of 5 to 20 rupees per dose for most over-the-counter formulations. Prescription Saccharomyces boulardii (Florastor in the US, similar names elsewhere) is often costlier. The reimbursement and supply picture varies, your local pharmacist can advise on what is in stock.

Who should not take probiotics

Probiotics are generally safe, but the live bacteria or yeast in them can rarely cause invasive infections in vulnerable patients. Five groups should avoid routine probiotic use unless a specialist specifically recommends them.

Avoid routine probiotic use

  • Critically ill patients in intensive care units (ICU)
  • Severely immunocompromised: chemotherapy, post-transplant, untreated HIV, long-term high-dose steroids, biologics with serious immunosuppression
  • Patients with central venous catheters or recent abdominal surgery
  • Premature infants outside specialised neonatal NEC-prevention protocols
  • Anyone with previous probiotic-associated bloodstream infection
  • Patients with short gut syndrome or severely disrupted gut barriers

Generally safe with probiotics

  • Healthy adults on a typical antibiotic course
  • Children with intact immunity on antibiotics for common infections
  • Adults over 65 in the community, on antibiotics for outpatient infections
  • Diabetes patients with good glycaemic control
  • Pregnant women in second and third trimester (with doctor's clearance for first trimester)
  • Breastfeeding mothers

The rare adverse events worth knowing about are Saccharomyces fungaemia in central-line patients, and Lactobacillus bacteraemia in immunocompromised hosts. Both are extremely uncommon in healthy outpatients but more common in critically ill or central-line populations, which is why the routine ICU recommendation is to avoid them.

Pregnancy and children

First trimester pregnancy

Discuss with your obstetrician before starting. Most probiotics in this list have no documented teratogenicity, but routine use in the first trimester is not formally studied. The safer course is to clear the decision with your doctor.

Second and third trimester

Generally safe. Saccharomyces boulardii and several Lactobacillus strains have been used in studies without adverse outcomes. Confirm the choice with your obstetrician, especially if you have any pregnancy complications.

Breastfeeding

Compatible. The probiotic does not reach the breastmilk in any way that would harm the infant. Reasonable to use during your antibiotic course.

Children

Probiotic AAD prevention is best studied in children. Lactobacillus rhamnosus GG and Saccharomyces boulardii both have strong paediatric evidence. Bacillus clausii is widely used in Asia for paediatric AAD. Doses are age and weight-based; ask your paediatrician or pharmacist for the right product.

Premature infants

Probiotic use for necrotising enterocolitis prevention in preterm low-birthweight infants is a specialised NICU decision, not a general outpatient one. The AGA 2020 guideline recommends specific formulations only in supervised neonatal protocols.

Adults over 65 in community

Higher baseline risk of C. difficile makes probiotic prevention more valuable. The CDC and Cochrane evidence both support strain-specific use. Talk to your doctor if you have multiple comorbidities or take a proton pump inhibitor (PPI), which itself increases C. difficile risk.

What to do if diarrhoea starts despite probiotics

Probiotics reduce the risk of AAD and C. difficile but do not eliminate it. Some patients still develop loose stools on antibiotics. Most of the time this is mild antibiotic-associated diarrhoea that resolves with hydration and gut flora recovery after the course ends.

Stop home management and contact your doctor for any of the following.

  • Watery diarrhoea more than 3 times a day for more than 24 hours.
  • Blood, mucus, or pus in the stool.
  • Fever above 38 degrees Celsius alongside diarrhoea.
  • Severe abdominal cramps or distension.
  • Signs of dehydration: dry mouth, no urine for 8 hours, dizziness when standing.
  • Worsening of diarrhoea after the antibiotic course ends, particularly within 8 weeks.
  • Age above 65, pregnancy, or immunocompromised state with any of the above.

The doctor will usually send a stool sample for C. difficile testing and review whether the antibiotic can be stopped or changed. Treatment for confirmed C. difficile colitis is with specific antibiotics like vancomycin or fidaxomicin, sometimes with continued probiotic support.

A note from Dr. Ravi Sishir Reddy

In my outpatient practice, I prescribe a probiotic alongside the antibiotic for most adults on a broad-spectrum course, particularly amoxicillin-clavulanate, clindamycin, fluoroquinolones, and any prolonged regimen above 7 days. The strain I recommend most often is Saccharomyces boulardii CNCM I-745 because the evidence is strongest for both AAD and C. difficile prevention. I tell patients three things: take it 2 hours after the antibiotic, continue for a week after the course ends, and stop and call me if you get fever with diarrhoea or blood in the stool. The harm I am preventing is not just the inconvenience of loose stools, it is C. difficile, which I have admitted multiple elderly patients with over my career. The cost-benefit favours probiotics for most of my outpatients.

Frequently asked questions

Should I take probiotics with antibiotics?

For most adults taking antibiotics, yes, evidence supports specific probiotic formulations to reduce the risk of antibiotic-associated diarrhoea and Clostridioides difficile colitis. The American Gastroenterological Association 2020 guideline recommends certain formulations for C. difficile prevention in adults and children on antibiotics. Strain selection matters more than brand. Some patients should not take probiotics, including those who are critically ill, severely immunocompromised, or have a central venous catheter.

Which probiotic strains have the strongest evidence?

Saccharomyces boulardii CNCM I-745 has the strongest evidence for both antibiotic-associated diarrhoea and Clostridioides difficile prevention in adults. Lactobacillus rhamnosus GG has strong evidence in children. The 3-strain and 4-strain combinations of Lactobacillus acidophilus, Lactobacillus delbrueckii bulgaricus, Bifidobacterium bifidum, and Streptococcus thermophilus also have evidence in the AGA guideline. Bacillus clausii has Asian expert consensus support for paediatric AAD. Generic Lactobacillus tablets without strain identification are not the same and may not work.

When should I start taking probiotics with antibiotics?

Start within 48 hours of the first antibiotic dose. Earlier is better because the goal is to maintain gut flora diversity from the beginning, not restore it after disruption. Continue throughout the antibiotic course and for at least 1 week after the last antibiotic dose. Some specialists recommend 2 weeks of probiotics after the antibiotic course ends, particularly after broad-spectrum agents like amoxicillin-clavulanate or fluoroquinolones.

How much time should I leave between the probiotic and the antibiotic?

At least 2 hours, ideally 3 hours. Take the antibiotic first and the probiotic 2 to 3 hours later, so the antibiotic concentration in the gut is lower when the probiotic bacteria arrive. Taking them at the same time exposes the live probiotic bacteria to the active antibiotic, which can kill or weaken them before they reach the colon.

Does yogurt count as a probiotic during antibiotics?

Mostly no. Regular yogurt and most curd contain useful live cultures but at colony-forming-unit (CFU) levels far below the doses used in clinical trials of probiotic supplements. Most studies that showed benefit used 1 to 50 billion CFU per day of specific strains. A serving of yogurt typically contains 1 million to 100 million CFU of unspecified strains. Yogurt is good food and gut-friendly, but it is not a substitute for a clinically validated probiotic if your goal is preventing antibiotic-associated diarrhoea.

Who should not take probiotics with antibiotics?

Five groups should avoid routine probiotic use: critically ill patients in intensive care units, severely immunocompromised patients including those on chemotherapy or post-transplant, patients with central venous catheters or recent abdominal surgery, premature infants outside specialised neonatal protocols, and anyone with a history of probiotic-associated bloodstream infection. In these groups, the small but real risk of probiotic-derived bacteraemia or fungaemia outweighs the benefit. Talk to your doctor.

What is the difference between antibiotic-associated diarrhoea and C. difficile colitis?

Antibiotic-associated diarrhoea (AAD) is loose stools caused by disrupted gut flora during or after antibiotic use. It affects 5 to 25 percent of adults on antibiotics and usually resolves on its own when the antibiotic stops. Clostridioides difficile colitis is a specific severe form of AAD caused by overgrowth of the C. difficile bacterium, which can cause watery diarrhoea, fever, abdominal pain, and life-threatening colitis. It needs medical treatment and sometimes hospitalisation. Probiotics reduce the risk of both.

Can I get probiotics from food alone?

For everyday gut health, fermented foods like yogurt, kefir, fresh idli batter, kimchi, sauerkraut, and miso provide a low-level steady supply of live cultures and are good for you. For the specific purpose of preventing antibiotic-associated diarrhoea during a course of antibiotics, the dose of live cultures from food is too low to match the doses used in clinical trials. A targeted probiotic supplement with a clinically studied strain is more reliable when prevention is the goal.

Medical disclaimer: This article is for general health education and does not replace consultation with a qualified healthcare professional. Probiotic recommendations are individual and depend on your underlying health, immune status, and the specific antibiotic prescribed. If you are critically ill, immunocompromised, or have a central venous catheter, talk to your doctor before starting any probiotic.

Get doctor-reviewed health guides every week.

Practical, no fluff, written for real life. Join readers across India, the UK, US, Canada, and Australia.

Subscribe free

About the author

247healthcare.blog editorial team writes general health and preventive medicine content reviewed by qualified doctors. Every article is fact-checked against current guidance from AGA, IDSA, Cochrane, WGO, NHS, CDC, and peer-reviewed medical literature before publication.

About the medical reviewer

Dr. Ravi Sishir Reddy (MBBS, MD General Medicine) is a Consultant Physician in Internal Medicine and Critical Care at Vivekananda Hospital, Begumpet, Hyderabad. He has 15 years of clinical experience including ICU care, infectious diseases, antibiotic stewardship, and gastroenterology. NMC-registered, verifiable on the Indian Medical Register.

Related reading on 247healthcare.blog

References

  1. American Gastroenterological Association. Clinical Practice Guideline on the Role of Probiotics in the Management of Gastrointestinal Disorders. AGA, 2020.
  2. Goldenberg JZ et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews, 2019.
  3. Goldenberg JZ et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews, updated 2017 and 2019.
  4. Infectious Diseases Society of America and SHEA. Clinical Practice Guideline by IDSA and SHEA: 2021 Focused Update on Management of Clostridioides difficile Infection in Adults.
  5. World Gastroenterology Organisation. Global Guidelines on Probiotics and Prebiotics. WGO, 2023.
  6. National Health Service. Probiotics overview. NHS UK.
  7. Centers for Disease Control and Prevention. Clostridioides difficile infection (CDI) guidance. CDC.
  8. De Castro JA et al. Recommendations for the adjuvant use of poly-antibiotic-resistant Bacillus clausii in pediatric diarrhoea: consensus from Asian experts, 2020.
Scroll to Top